Drug utilization in Belgian nursing homes: Impact of residents' and institutional characteristics

Pharmacoepidemiology and Drug Safety

Volumn 19, Issue 10, 2010, Pages 1041-1048

  Elseviers, Monique M ^a,b   Vander Stichele, Robert R ^b   Van Bortel, Luc ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Drug utilization; Health care costs; Health services research; Homes for the aged; Nursing homes; Pharmaceutical services

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIULCER AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LAXATIVE; NEUROLEPTIC AGENT; VASODILATOR AGENT; VITAMIN;

ADULT; AGED; ARTICLE; COMORBIDITY; CROSS-SECTIONAL STUDY; DEMENTIA; DRUG COST; DRUG USE; DRUG UTILIZATION; FEMALE; GENERAL PRACTITIONER; GROUPS BY AGE; HOSPITAL BED; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MEDICAL RECORD REVIEW; NURSING HOME; PALLIATIVE THERAPY; PHARMACIST; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL; REIMBURSEMENT; RESIDENT;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FEMALE; GENERAL PRACTITIONERS; HEALTH FACILITIES; HOMES FOR THE AGED; HUMANS; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; NURSING HOMES; PALLIATIVE CARE; PHARMACEUTICAL PREPARATIONS; POLYPHARMACY;

EID: 79251478031     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1983     Document Type: Article

References (29)

1. Van de Voorde C, Devriese S, De Falleur M, Ramaekers D. Organizational characteristics and aggregatedmedication use in Belgian rest and nursing homes. In Geneesmiddelengebruik in Belgische rusthuizen en rusten verzorgingstehuizen. Health Services Research (HSR). Federaal Kenniscentrum voor de gezondheidszorg (KCE): Brussel, KCE reports 47 A(D/2006/10.273/61), 2006; 3-26.
2. Johnell K, Fastbom J. Multi-dose drug dispensing and inappropriate drug use: a nationwide register-based study of over 700,000 elderly. Scand J Prim Health Care 2008; 26(2): 86-91.
3. Prudent M, Dramé M, Jolly D, et al. Potentially inappropriate use of psychotropic medications in hospitalized elderly patients in France: cross-sectional analysis of the prospective, multicentre SAFEs cohort. Drugs Aging 2008; 25(11): 933-946.
4. Leendertse AJ, Egberts AC, Stoker LJ, et al. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008; 168(17): 1890-1896.
5. Gallanger P, Barry P, O'Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther 2007; 32: 113-121.
6. Hughes CM, Roughead E, Kerse N. Improving use of medicines for older people in long-term care: contrasting the policy approach of four countries. Healthc Policy 2008; 3(3): e155-e167.
7. Vander Stichele R, Van de Voorde C, Elseviers M, et al. Geneesmiddelengebruik in Belgische rusthuizen en rusten verzorgingstehuizen. Health Services Research (HSR). Federaal Kenniscentrum voor de gezondheidszorg (KCE): Brussel, KCE reports 47 A(D/2006/10.273/61), 2006.
8. Katz S, Apkom CA. A measure of primary sociobiological functions. Int J Health Serv 1976; 6: 493-507.
9. Doshi JA, Shaffer T, Briesacher BA. National estimates of medication use in nursing homes: findings from the 1997 medicare current beneficiary survey and the 1996 Medical Expenditure Survey. J Am Geriatr Soc 2005; 53: 438-443.
10. Ramage-Morin PL. Medication use among senior Canadians. Health Rep 2009; 20(1): Statistics Canada no. 82-003-XPE
11. Olsson IN, Curman B, Engfeldt P. Patient focused drug surveillance of elderly patients in nursing homes. Pharmacoepidemiol Drug Saf 2010; 19: 150-157.
12. Mann E, Kopke S, Haastert B, et al. Psychotropic medication use among nursing home residents in Austria: a cross-sectional study. BMC Geriatr 2009; 9: 18.
13. Holmes HM, Cox Hayley D, Alexander GC, et al. Reconsidering medication appropriateness for patients late in life. Arch Intern Med 2006; 166: 605-609.
14. Hotopf M, Chidgey J, Addington-Hall J, et al. Depression in advanced disease: a systematic review. Part 1. Prevalence and case finding. Palliat Med 2002; 16(2): 81-97.
15. Delgado-Guay M, Parson HA, Li Z, et al. Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting. Support Care Cancer 2009; 17: 573-579.
16. Gill D, Hatcher S. Antidepressants for depression in medical illness. Cochrane Database Syst Rev 2000; 4: CD001312.
17. Nygaard HA, Naik M, Ruths S, et al. Nursing-home residents and their drug use: a comparison between mentally intact and mentally impaired residents-The Bergen District Nursing Home (BEDNURS) study. Eur J Clin Pharmacol 2003; 59(5-6): 463-469.
18. Reynolds KS, Hanson LC, DeVellis RF, et al. Disparities in pain management between cognitively intact and cognitively impaired nursing home residents. J Pain Symptom Manage 2008; 35: 388-396.
19. Sutcliff C, Burns A, Challis D, et al. Depressed mood, cognitive impairment, and survival in older people admitted to care homes in England. Am J Geriatr Psychiatry 2007; 15(8): 708-715.
20. Bains J, Birks JS, Dening TR. The efficacy of antidepressants in the treatment of depression in dementia. Cochrane Database Syst Rev 2002; 4: CD003944.
21. Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing-home residents. Arch Intern Med 1991; 151(3): 338-346.
22. Hanlon JT, Schmader KE, Boult C, et al. Use of inappropriate prescription drugs by older people. J Am Geriatr Soc 2002; 50(1): 26-34.
23. Handler SM, Wright RM, Ruby CM, et al. Epidemiology of medication-related adverse events in nursing homes. Am J Geriatr Pharmacother 2006; 4(3): 264-272.
24. Hosia-Randell HM, Muurinen SM, Pitkälä KH. Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study. Drugs Aging 2008; 25(8): 683-692.
25. Hughes CM, Lapane KL. Administrative initiatives for reducing inappropriate prescribing of psychotropic drugs in nursing homes. How successful have they been? Drugs Aging 2005; 22: 339-351.
26. Nishtala PS, McLachlan AJ, Bell JS, et al. Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions. Am J Geriatr Psychiatry 2008; 16(8): 621-632.
27. Verrue CL, Petrovic M, Mehuys E, et al. Pharmacists' interventions for optimization of medication use in nursing homes: a systematic review. Drugs Aging 2009; 26(1): 37-49.
28. Wenger NS, Shekelle PG. Assessing care of vulnerable elders: ACOVE project overview. Ann Intern Med 2001; 135(8): 642-646.
29. Fick DM, Cooper JW, Wade WE, et al. Updating the beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163(22): 2716-2724.